CN Patent

CN101336248A — 与pea-15相互作用的新型化合物

Assigned to Institut National de la Sante et de la Recherche Medicale INSERM · Expires 2008-12-31 · 17y expired

What this patent protects

本发明涉及能够与PEA－15蛋白相互作用的、确定的式的新型假肽化合物，和涉及其在筛选方法中的用途，和涉及可能牵涉PEA－15的病理学状况的诊断方法。

USPTO Abstract

本发明涉及能够与PEA－15蛋白相互作用的、确定的式的新型假肽化合物，和涉及其在筛选方法中的用途，和涉及可能牵涉PEA－15的病理学状况的诊断方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101336248A
Jurisdiction
CN
Classification
—
Expires
2008-12-31
Drug substance claim
No
Drug product claim
No
Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.